Valion Bio, Inc. (VBIO) - Halal (Shariah-Compliant)
Valion Bio, Inc. (VBIO) is classified as Halal (Shariah-Compliant) according to AAOIFI Shariah screening standards. This assessment is based on business activity screening and financial ratio analysis using the AAOIFI methodology.
Business Activity Screen
- Sector
- Healthcare
- Industry
- Biotechnology
- Result
- Pass
- Reason
- The sector "Healthcare" and industry "Biotechnology" are not in the excluded categories.
Financial Ratios
- Debt Ratio
- Value: 24.7% | Threshold: 30% | Result: Pass
- Cash & Interest-bearing Securities Ratio
- Value: 3.0% | Threshold: 30% | Result: Pass
- Non-Permissible Income Ratio
- Value: 0.1% | Threshold: 5% | Result: Pass
Dividend Purification
Purification percentage: 0.08%.Based on the company's financial statements, approximately 0.08% of dividend income should be donated to charity for purification. This is derived from identified interest income (0.08% of total income). Some scholars may differ on the exact calculation method.
About Valion Bio, Inc.
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Frequently Asked Questions
Is Valion Bio, Inc. (VBIO) stock halal to invest in?
According to AAOIFI Shariah screening standards, Valion Bio, Inc. (VBIO) is currently classified as Halal (Shariah-Compliant). This is based on both business activity and financial ratio screening.
Does Valion Bio, Inc. have any interest income?
Valion Bio, Inc.'s interest income ratio is 3.0% of total revenue. AAOIFI standards require this to be below 30%.

